News · 26 weeks61-29%
2026-03-012026-08-23
Mix2890d
- Insider14(50%)
- SEC Filings7(25%)
- Other3(11%)
- Earnings2(7%)
- Leadership1(4%)
- Offering1(4%)
Latest news
25 items- SECTeladoc Health Inc. filed SEC Form 8-K: Leadership Update8-K - Teladoc Health, Inc. (0001477449) (Filer)
- INSIDERSEC Form 4 filed by Director Anquillare Mark V4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERSEC Form 3 filed by new insider Anquillare Mark V3 - Teladoc Health, Inc. (0001477449) (Issuer)
- SECTeladoc Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Teladoc Health, Inc. (0001477449) (Filer)
- PRTeladoc Health Appoints Financial Executive Mark Anquillare to Its Board of DirectorsNEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former president and chief operating officer of Verisk Analytics, a strategic data analytics and technology partner to the global insurance industry. He will serve on the board’s Audit & Compensation committees. "Mark’s leadership across the global insurance and analytics sectors, along with his experience guiding public companies through growth and transformation, makes him an outstanding addition to the Board," said Kenneth H. Paulus, non-executive Chairman of the Teladoc Health b
- SECSEC Form 10-Q filed by Teladoc Health Inc.10-Q - Teladoc Health, Inc. (0001477449) (Filer)
- SECTeladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Teladoc Health, Inc. (0001477449) (Filer)
- PRTeladoc Health Reports Second Quarter 2026 ResultsNEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 ("Second Quarter 2026"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2025 ("Second Quarter 2025"). Highlights Second Quarter 2026 revenue of $606.9 million, down 4% year-over-yearSecond Quarter 2026 net loss of $38.9 million, or $0.21 per shareSecond Quarter 2026 adjusted EBITDA of $65.7 million, down 5% year-over-yearIntegrated Care segment revenue of $394.3 million, up 1% year-over-year, and adjusted EBITDA margin of 16.5%BetterHelp segment reven
- PRTeladoc Health introduces a virtual care practice built around the person, shaping a new era of connected careTeladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care Multidisciplinary care teams, paired with always-on AI support, deliver and guide every step of care NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the pioneer and global leader in virtual care, today announced Teladoc One — a fundamentally new model of virtual care. Teladoc One begins with the person. It addresses the industry's longstanding challenge of fragmented care, where solutions have been built to address one disease at a time rather than dynamically supporting a person's entire health needs.
- PRTeladoc Health to Announce Second Quarter 2026 Financial ResultsNEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the meeting ID # 478 236 923. For international participants, please visit the following link for global dial-in numbers, using the same meeting ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers. A live audio webca
- INSIDERPresident, U.S. Group Health Bliss Kelly sold $23,750 worth of shares (2,500 units at $9.50) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 84,878 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERChief Accounting Officer Catapano Joseph Ronald converted options into 2,083 shares and sold $5,942 worth of shares (653 units at $9.10), increasing direct ownership by 13% to 12,267 units (SEC Form 4) to satisfy withholding obligation4 - Teladoc Health, Inc. (0001477449) (Issuer)
- PRTeladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of BetterHelp, David Packles was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value $0.001 per share ("Common Stock"). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The award was approved b
- INSIDERPresident, U.S. Group Health Bliss Kelly sold $22,500 worth of shares (2,500 units at $9.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 87,378 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERPresident, U.S. Group Health Bliss Kelly sold $21,250 worth of shares (2,500 units at $8.50) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 89,878 units (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- PRSenesTech Appoints Jack Karabees as Executive Vice President of SalesVeteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizationsSURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales. Mr. Karabees brings more than three decades of experience building and leading professional B2B sales organizations and helping companies define the processes and systems necessary to achieve significant scale. In his
- INSIDERCHIEF EXECUTIVE OFFICER Divita Charles Iii sold $125,470 worth of shares (18,074 units at $6.94) and converted options into 42,802 shares, increasing direct ownership by 6% to 414,622 units (SEC Form 4) to cover taxes4 - Teladoc Health, Inc. (0001477449) (Issuer)
- SECSEC Form 144 filed by Teladoc Health Inc.144 - Teladoc Health, Inc. (0001477449) (Subject)
- INSIDERPresident of BetterHelp Rodrigues Fernando M. sold $70,833 worth of shares (9,572 units at $7.40) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERPresident of BetterHelp Rodrigues Fernando M. converted options into 15,249 shares and sold $43,298 worth of shares (5,677 units at $7.63) (SEC Form 4) (withholding tax)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERCHIEF LEGAL OFFICER, SECRETARY Vandervoort Adam C converted options into 14,928 shares and sold $60,299 worth of shares (7,906 units at $7.63), increasing direct ownership by 7% to 110,261 units (SEC Form 4) to satisfy tax liability4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERCHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 44,242 shares and sold $145,920 worth of shares (19,132 units at $7.63), increasing direct ownership by 7% to 389,894 units (SEC Form 4) (for tax liability)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERPresident, International Nueno Carlos converted options into 13,272 shares and sold $47,257 worth of shares (6,196 units at $7.63), increasing direct ownership by 14% to 57,671 units (SEC Form 4) (for tax liability)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERChief Accounting Officer Catapano Joseph Ronald converted options into 872 shares and sold $2,166 worth of shares (284 units at $7.63), increasing direct ownership by 6% to 10,837 units (SEC Form 4) (tax liability)4 - Teladoc Health, Inc. (0001477449) (Issuer)
- INSIDERPresident, U.S. Group Health Bliss Kelly converted options into 15,310 shares and sold $58,568 worth of shares (7,679 units at $7.63), increasing direct ownership by 9% to 92,378 units (SEC Form 4) (for withholding tax)4 - Teladoc Health, Inc. (0001477449) (Issuer)
TDOC FAQ
7 questionsWhat does Teladoc Health Inc. do?
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers...Where does TDOC stock trade?
Teladoc Health Inc. (TDOC) is listed on NYSE.What sector and industry is TDOC in?
Teladoc Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did Teladoc Health Inc. go public?
Teladoc Health Inc. (TDOC) completed its IPO in 2015.What are analysts saying about TDOC?
Teladoc Health Inc. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Buy with a $1100.00 price target on 2026-03-10. Recent price targets range from $700.00 to $2200.00.What companies are similar to TDOC?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), LFST (LifeStance Health Group Inc.), AMED (Amedisys Inc). Compare TDOC side-by-side with any of them on Quantisnow.How can I track TDOC on Quantisnow?
Quantisnow aggregates Teladoc Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TDOC to receive live email and push alerts on every new disclosure.